ArticleFrontiers in neuroimaging2026
A rapid streamline-based extension of Tractfinder for white matter tract segmentation.
Article in Frontiers in neuroimaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate delineation of white matter tracts is critical in the pre-operative assessment of paediatric brain tumour patients, where preservation of eloquent pathways directly influences surgical planning and functional outcomes. Tractfinder is a recently introduced automated method for white matter tract segmentation in tumour patients, but its voxel-based (mask) outputs limit compatibility with streamline-based tractography tools, visualisation workflows, and downstream analytical frameworks. Here we introduce Tractfinder-constrained Tractography (TcT), a streamline-based extension that constrains probabilistic tractography to the probability maps produced by Tractfinder, generating streamline representations while preserving the speed and automation that make Tractfinder clinically appealing. We evaluated TcT in ten pre-operative paediatric patients with supratentorial tumours, targeting three clinically relevant tracts - the corticospinal tract, arcuate fasciculus, and optic radiation. Spatial agreement between TcT and conventional tractography was assessed using Bundle Adjacency (BA). Mean BA scores across all three tracts ranged from 2.1 to 2.6 mm, comparing favourably against published inter-protocol benchmarks for conventional probabilistic tractography (4.3 mm), and approaching within-protocol variability. The TcT pipeline was fully automated, required no manual region-of-interest placement, and completed in approximately 5-15 min per subject compared to 1-2 h for conventional tractography. These results demonstrate that TcT produces streamline-based tract segmentations with good spatial agreement to conventional tractography, while offering substantially reduced processing time and operator burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.